Navigation Links
Study Finds GanedenBC30 Probiotic Supports Digestive and Immune Health in Healthy Seniors
Date:8/27/2013

Cleveland, OH (PRWEB) August 27, 2013

Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, and Reckitt Benckiser (RB), announce that GanedenBC30 probiotic supports digestive and immune health in healthy seniors, according to research just released at the University of Reading, England.

The results of the randomized, double-blind, placebo-controlled cross-over study could have huge implications for the population of individuals over 65 that is growing at the fastest rate in history--an American turns 65 every 13 seconds; approximately 10,000 baby boomers retire every day.

The study demonstrated that GanedenBC30 supports digestive (increased healthy bacteria in the gut) and immune health (improved immune markers) in a healthy senior population.

Senior author of the study, Glenn Gibson, professor of Food Microbial Sciences at the University of Reading and president and founding member of the International Scientific Association for Probiotics and Prebiotics, said: “When you are younger, you have a healthier balance of good and bad bacteria. As people age this balance shifts, and often the bad bacteria in the gut increases. In addition, people begin to experience more gastro-intestinal (GI) issues, along with changes in immune function as the majority of your immune cells are in the gut.”

“This study has helped us gain a better understanding of how age affects the gut and to further establish that GanedenBC30 can help support GI and immune health,” said David Keller, Vice President of Scientific Operations, Ganeden Biotech.

Full results are being prepared for publication.

###

About GanedenBC30:
Ganeden Biotech’s leading probiotic, GanedenBC30 (Bacillus coagulans GBI-30, 6086), is a patented, organism that can be found in more than 80 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains used in food and beverages, GanedenBC30 is highly stable and can remain viable through processing, shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 17 published studies. GanedenBC30 has an exceptional safety record and FDA GRAS status from the United States Food and Drug Administration. For more information, please visit http://www.GanedenBC30.com.

About Ganeden Biotech:
Founded in 1997 the Cleveland, Ohio-based Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 80 leading food and beverage products. A highly stable probiotic ingredient with physical properties that make it more stable than traditional probiotic organisms (such as Lactobacillus and Bifidobacterium); GanedenBC30 is ideally suited for almost any food, beverage or companion animal application. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. It can easily be incorporated in virtually any lotion, cream, soap, shampoo or other personal care product. Ganeden is more than an ingredient supplier; Ganeden works with its clients as a partner, taking special care to add value from initial contact to product launch and beyond. For more information about Ganeden Biotech and licensing opportunities visit http://www.GanedenBiotech.com.

About Reckitt Benckiser (RB):
Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and home.

With a purpose of delivering innovative solutions for healthier lives and happier homes, Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by brands including Digestive Advantage, MegaRed, MoveFree, Airborne, Mucinex, Lysol and Air Wick.

The company has operations in over 60 countries, with headquarters in the UK, Singapore, Dubai and Amsterdam, and sales in almost 200 countries. The company employs approximately 38,000 people worldwide. For more information, visit http://www.RB.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11065649.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... planning services from offices headquartered in Jefferson County, is announcing the launch of ... in Birmingham. , The number of homeless women and children in Birmingham has ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit ... Standard. To learn more about Diplomat,s career opportunities, visit ... ... ... LLC, a research firm specializing in organizational health and workplace improvement. ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... and Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Electrodes Market is poised to grow at a CAGR of around ... the market is witnessing include advancements in extracellular microelectrode arrays and ...
Breaking Medicine Technology: